ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Vanderbilt-Ingram Cancer Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Vanderbilt-Ingram Cancer Center takes part in 4 sessions at ESMO 2026 in Madrid. Its sessions focus on treatment strategies and biomarkers in kidney cancer. They examine a bispecific antibody that blocks PD-1 and VEGF, with or without other drugs, in advanced or metastatic kidney cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Vanderbilt-Ingram Cancer Center Nashville, TN | |
NCI-designated comprehensive cancer centre of the private Vanderbilt University Medical Center in Nashville, Tennessee. | Satellite Fri Oct 23 09:45–11:15 Eisai - RCC in Motion: First-Line Choice and the Evolving RCC Treatment Landscape Genitourinary cancers Satellite Fri Oct 23 09:45–09:48 Welcome and Introduction Genitourinary cancers Satellite Fri Oct 23 10:43–10:58 Emerging Second-Line Treatment Strategies Genitourinary cancers Satellite Fri Oct 23 11:08–11:15 RCC Treatment Landscape, Future Directions and Closing Remarks Genitourinary cancers Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Evaluation of peripheral biomarkers in ccRCC patients treated with the HIF-2α inhibitor casdatifan Genitourinary cancersBiomarkers & precision oncology Talk Mon Oct 26 08:30–08:50 Presentation by Expert Gastrointestinal cancers |
Find decision makers at Vanderbilt-Ingram Cancer Center
Tell us what you sell and we’ll find the people at Vanderbilt-Ingram Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction